Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: Exploratory analyses by baseline prostate-specific antigen doubling time: Editorial comment

Samir S. Taneja

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: Exploratory analyses by baseline prostate-specific antigen doubling time: Editorial comment'. Together they form a unique fingerprint.